Where are the guidelines for the treatment of asthma with panic spectrum symptoms? [2] (multiple letters)

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 8, 2005, Pages 1055-1056

  Nardi, Antonio E ^a   Hasler, Gregor ^b,c   Gergen, Peter J ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIPANIC AGENT; CAFFEINE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR;

ASTHMA; BRONCHODILATATION; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DAILY LIFE ACTIVITY; DOSE RESPONSE; EARLY DIAGNOSIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LOCUS CERULEUS; PANIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; SMOKING; SPIROMETRY;

EID: 26944441616     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/ajrccm.172.8.952     Document Type: Letter

References (0)